Montrusco Bolton Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-54,622
Closed -$15M 61
2020
Q3
$15M Buy
54,622
+2,641
+5% +$737K 0.75% 44
2020
Q2
$13.8M Sell
51,981
-82,143
-61% -$24.7M 0.79% 41
2020
Q1
$40.7M Buy
134,124
+87,756
+189% +$26.6M 3.21% 9
2019
Q4
$13.3M Sell
46,368
-42,804
-48% -$11.9M 0.77% 42
2019
Q3
$26.1M Buy
89,172
+1,052
+1% +$245K 1.54% 23
2019
Q2
$20.2M Buy
88,120
+24,636
+39% +$5.69M 1.32% 26
2019
Q1
$14.3M Buy
63,484
+2,877
+5% +$906K 0.92% 36
2018
Q4
$18M Buy
60,607
+4,266
+8% +$1.36M 1.22% 26
2018
Q3
$19.9M Buy
56,341
+13,490
+31% +$4.64M 1.22% 25
2018
Q2
$12.4M Sell
42,851
-4,907
-10% -$1.38M 0.86% 28
2018
Q1
$13M Buy
47,758
+10,713
+29% +$3.33M 0.94% 27
2017
Q4
$11.8M Sell
37,045
-2,403
-6% -$771K 0.64% 36
2017
Q3
$12.3M Buy
39,448
+745
+2% +$221K 0.65% 37
2017
Q2
$10.5M Buy
38,703
+9,973
+35% +$2.64M 0.58% 40
2017
Q1
$7.84M Sell
28,730
-263
-0.9% -$74.4K 0.44% 46
2016
Q4
$8.2M Sell
28,993
-7,928
-21% -$2.35M 0.45% 45
2016
Q3
$11.5M Sell
36,921
-7,128
-16% -$2.11M 0.71% 32
2016
Q2
$10.6M Sell
44,049
-4,397
-9% -$1.16M 0.68% 36
2016
Q1
$12.6M Sell
48,446
-6,417
-12% -$1.7M 1.04% 28
2015
Q4
$16.7M Buy
54,863
+25,180
+85% +$7.24M 1.45% 24
2015
Q3
$8.65M Sell
29,683
-14
-0% -$4.62K 0.74% 41
2015
Q2
$12M Buy
29,697
+28,667
+2,783% +$11.5M 0.89% 37
2015
Q1
$435K Buy
+1,030
New +$406K 0.03% 71
2014
Q4
Sell
-2,680
Closed -$887K 86
2014
Q3
$887K Sell
2,680
-220
-8% -$72.5K 0.06% 67
2014
Q2
$914K Buy
+2,900
New +$873K 0.06% 70

Other funds holding BIIB

Montrusco Bolton Investments's BIIB Position: Q4 2020 in Review

Montrusco Bolton Investments sold out of Biogen (BIIB) in Q4 2020, closing a stake of 54,622 shares — an estimated $15M sold.

Montrusco Bolton Investments first reported a position in BIIB in Q2 2014 and held it in 25 quarters. The position peaked at $40.7M in Q1 2020. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Montrusco Bolton Investments reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Montrusco Bolton Investments sold 54,622 Biogen shares in Q4 2020, an estimated $15M.
  • Montrusco Bolton Investments first reported a position in Biogen in Q2 2014 and held it in 25 quarters.
  • Montrusco Bolton Investments's Biogen position peaked at $40.7M in Q1 2020.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Montrusco Bolton Investments's 13F filing for Q4 2020, filed 16 Feb 2021.